Restenosis - Pipeline Review, H2 2018

Publisher Name :
Date: 07-Aug-2018
No. of pages: 44
Inquire Before Buying

Restenosis - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restenosis - Pipeline Review, H2 2018, provides an overview of the Restenosis (Cardiovascular) pipeline landscape.

Restenosis is re-narrowing of a blood vessel which leads to restricted blood flow. Symptoms include shortness of breath, difficulty walking and chest pain. Risk factors include increasing age, gender, family history or race and diabetes. Treatment includes surgery and thrombolytic therapy.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Restenosis - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Restenosis (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Restenosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Restenosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II and Preclinical stages are 1 and 2 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 2 molecules, respectively.

Restenosis (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Restenosis (Cardiovascular).

- The pipeline guide reviews pipeline therapeutics for Restenosis (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Restenosis (Cardiovascular) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Restenosis (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Restenosis (Cardiovascular)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Restenosis (Cardiovascular).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Restenosis (Cardiovascular) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Restenosis - Pipeline Review, H2 2018

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Restenosis - Overview
Restenosis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Restenosis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Restenosis - Companies Involved in Therapeutics Development
CytoTools AG
XBiotech Inc
Restenosis - Drug Profiles
(connective tissue growth factor + insulin human) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HMW-02Ak - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HMW-02Ap - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TW-01 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Xilonix - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Restenosis - Dormant Projects
Restenosis - Discontinued Products
Restenosis - Product Development Milestones
Featured News & Press Releases
Jan 03, 2013: XBiotech Receives Fast Track Designation From FDA For True Human Monoclonal Antibody Therapy Targeting Inflammatory Cytokine IL-1a For Restenosis
Nov 20, 2012: XBiotech Reports Positive Phase II Interim Analysis Results Of MABp1 In Vascular Disease
Aug 18, 2011: XBiotech Announces Initiation Of Restenosis Clinical Trial In All Five US Sites
Dec 22, 2010: XBiotech Files IND For CV-18C3 Monoclonal Antibody Therapy To Treat Peripheral Vascular Disease
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Restenosis, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Restenosis - Pipeline by CytoTools AG, H2 2018
Restenosis - Pipeline by XBiotech Inc, H2 2018
Restenosis - Dormant Projects, H2 2018
Restenosis - Dormant Projects, H2 2018 (Contd..1), H2 2018
Restenosis - Discontinued Products, H2 2018

List of Figures
Number of Products under Development for Restenosis, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products by Routes of Administration, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Molecule Types, H2 2018
Number of Products by Stage and Molecule Types, H2 2018
  • Global and Chinese Myocardial Ischemia Drugs Industry, 2018 Market Research Report
    Published: 14-Jan-2019        Price: US 3000 Onwards        Pages: 142
    The 'Global and Chinese Myocardial Ischemia Drugs Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Myocardial Ischemia Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Myocardial Ischemia Drugs manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of th......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Myocardial Infarction Drugs Market 2018, Forecast to 2023
    Published: 11-Jan-2019        Price: US 4880 Onwards        Pages: 137
    Myocardial infarction, commonly known as heart attack, occurs due to reduced blood flow to a part of the heart, causing damage to the heart muscle. The medications, which are used to treat heart attacks are known as myocardial infarction drugs. The reduced blood flow further causes blockage in the supply of oxygen to the heart, which is due to atherosclerosis, a process in which the plaque is formed on the inside wall of the coronary vein or one of its minor branches. Myocardial infraction occur......
  • Global Myocardial Infarction Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 11-Jan-2019        Price: US 3480 Onwards        Pages: 130
    Myocardial infarction, commonly known as heart attack, occurs due to reduced blood flow to a part of the heart, causing damage to the heart muscle. The medications, which are used to treat heart attacks are known as myocardial infarction drugs. The reduced blood flow further causes blockage in the supply of oxygen to the heart, which is due to atherosclerosis, a process in which the plaque is formed on the inside wall of the coronary vein or one of its minor branches. Myocardial infraction occur......
  • Global and Chinese Digoxin Industry, 2018 Market Research Report
    Published: 10-Jan-2019        Price: US 3000 Onwards        Pages: 146
    The 'Global and Chinese Digoxin Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Digoxin industry with a focus on the Chinese market. The report provides key statistics on the market status of the Digoxin manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, applications and ......
  • Global Heart Failure Drugs Market Insights, Forecast to 2025
    Published: 10-Jan-2019        Price: US 3900 Onwards        Pages: 119
    The global heart failure drugs market is generic in nature; as many generic drug manufacturers and pharmaceutical giants are providing drugs for a disease. However; the arrival of innovative drugs such as EOM, is expected to change the market dynamics. AstraZeneca and Novartis hold the major share of the global heart failure drugs market with their drugs Toprol-XL and wog, respectively. The companies also hold a strong pipeline and are expected to remain the market leaders during the forecast pe......
  • Global and Chinese Cilostazol Industry, 2018 Market Research Report
    Published: 09-Jan-2019        Price: US 3000 Onwards        Pages: 135
    The 'Global and Chinese Cilostazol Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Cilostazol industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cilostazol manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, applicat......
  • Global and Chinese Simvastatin Industry, 2018 Market Research Report
    Published: 05-Jan-2019        Price: US 3000 Onwards        Pages: 145
    The 'Global and Chinese Simvastatin Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Simvastatin industry with a focus on the Chinese market. The report provides key statistics on the market status of the Simvastatin manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, appli......
  • Global Congestive Heart Failure Drugs Market Insights, Forecast to 2025
    Published: 04-Jan-2019        Price: US 3900 Onwards        Pages: 120
    The global Congestive Heart Failure Drugs market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Congestive Heart Failure Drugs market based on company, product type, end user and key regions. This report studies the global market size of Congestive Heart Failure Drugs in key regions like North America, Europe, Asia Pacific, Centra......
  • Global Statin Market Insights, Forecast to 2025
    Published: 02-Jan-2019        Price: US 3900 Onwards        Pages: 114
    Statins are special class of drugs that helps in lowering of blood cholesterol level in the body. This is prescribed to lower down the low density lipoprotein (LDL) cholesterol in the body and thus reduce mortality in high risk patients.  Rise in prevalence of cholesterol owing to changing lifestyle has led to increased demand for statins worldwide. As per the WHO, Europe followed by North America has witnessed highest elevated total cholesterol level worldwide. There has been a significa......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs